Articles

Psychiatrists Have Become Our Jailers   June 5, 2026 – Robert Carter       Three hundred years ago, as commerce drove the Western world to abandon farms and populate cities, more and more “lunatics” appeared on the streets. Poverty, malnutrition, and probably just plain isolation spurred an increasingly larger group of people who had suddenly became a “problem” for the rest of “civilized” society.      The asylum was born. The early institutions that housed these poor souls were for the most part cruel jails for those who had committed no crime. The “insane” were warehoused in away from society and were often starved while chained to walls and left to rot far way from the easily offended eyes of a new urban middle class.      By the early nineteenth century an effort was made to rehabilitate the “mad” through moral treatment sanctuaries that offered a kinder treatment with the goal of returning these “deviants” to productive lives. That movement did not last long, however, perhaps given the huge growth of urban metropolises and the need for confining these abnormal folks in larger and larger, more and more punitive, and less and less rehabilitative institutions.      It was at this time that psychiatrists found their niche. These newly evolved “doctors of the mind” had for some reason set their sights on analyzing the insane – not the mentally healthy – to develop their practice. These dark madhouses, hidden from society, provided them with perfect laboratories to develop their cruel “treatments” of insulin coma therapy, electroshock, and lobotomies.      All those treatments the World Health Organization now lists as torture. Behind he alls of these jail-like institutions, out of the public eye, psychiatrists could destroy one body after another in their mad efforts to cure insanity. Instead, they ended up jailing thousands of unfortunate souls in their own damaged bodies.      Once the extent of these institutional horrors were exposed to the public in the early 1950s – – and lobotomies were made illegal and ECT was at least curtailed — psychiatrists had to find another means of jailing those they considered insane.      Bingo. Thorazine was created, and three quarters of a century of debilitating psychotropic drugs have followed in its path. Any “unhappy” soul can now be imprisoned in a body poisoned by these toxic chemicals prescribed by a psychiatrist who’s chosen the right DSM label for someone’s “lunacy.”      Today eighty million American souls on antidepressants have become incarcerated in their own body jails. With the help of Big Pharma’s bogus marketing, they have come to believe they are now somehow free from life’s tribulations.      There’s only one tribulation in any kind in a jail, though…the tribulation of not being free.

Big Pharma Authors Are a Corrupt Crowd   May 28, 2026 – Robert Carter      A recent study published in the Spanish health journal Gaceta Sanitaria shows that eighty percent of 704 Big Pharma clinical practice guideline authors received some form of compensation by pharmaceutical companies. The research was done by Spain’s Department of Public Health and it assessed the honesty of those authors to report any conflict of interest industry compensation.      One third of those authors whose public records show compensation from Big Pharma filed no required conflict of interest statements. Ten percent of them did file, but claimed they had received no Big Pharma payments, despite the public records showing they did. Another ten percent claimed some compensation, but not all of their pharmaceutical industry payments.      In fact, the Department of Public Health concluded that only seventeen percent of the 704 clinical practice guideline authors had reported their Big Pharma compensation at all reliably. That’s quite a collection of dishonest folks. That’s quite a corrupt industry where that many employees accept Big Pharma bribes and then lie about them.      Yes, this is a study in Spain only. Yes, it only covers a six year span, but it’s recent, 2017- 2023. Yes, the payments reported to these authors came from pharmaceutical records and themselves may therefore not be the most reliable admission of compensation. Is it possible that this level of corruption is only unique to Spain? Yes…but that is highly unlikely.      The greater probability is that this study reveals a level of dishonesty prompted by the lavish compensation by Big Pharma to these authors. They are apparently willing to work in an inherently evil industry, producing harmful drugs, because they have been so well bribed by the financial rewards available to them there.      Big Pharma greed breeds more greed, both in employer and employees.      Thanks to Richard Sears for bringing attention to this study in his recent Mad in America post.

Cult Recovery Steps Work for Psychiatric Drug Survivors Too   May 22, 2026 – Robert Carter      Kelsey Decker spent eight years in a high-control spiritual group, The Ishaya’s Ascension. Also known as The Bright Path, it offered costly brainwashing meditative techniques under an authoritarian leadership. She managed to extricate herself from it twenty years ago, but spent the first ten years struggling to reorient herself to real life and to her real self. At first, she hadn’t even known she had been in a cult.|      She has now published The Unofficial Survival Guide to help others recover from similarly destructive manipulation in other “cults.” She lists eighty-nine specific tips for recovery as survivors progresses through eight general aspects of restoring themselves after suffering the trauma of destructive manipulation by a cult.Those eight aspects of recovery apply equally as well to anyone who has been harmed by the “cult” of psychiatric medicine. They include nervous system and psychological healing, identity reconstruction, relationships and social recovery, and spiritual recovery.      Long term ingestion of such toxic substances as Lexapro, Zoloft, Prozac, and Celexa disrupt the natural harmony of the nervous system and consequently the stability of one’s psyche. A safe, slow tapering off these drugs is essential before a full recovery can occur and a sane reconstruction of one’s identity can begin.A psychiatric patient has been told by an “authority” who cannot be challenged and who “knows” more than any patient does – in other words, the psychiatrist – that one has a mental disorder occasioned by a chemical imbalance. One is therefore stigmatized for life because of one’s mental “disease.” All false, of course, but often difficult labels to get out of one’s head.      A person recovering from psychiatric treatment often needs to reestablish bonds with family and community. The semi-zombie state that these drugs can induce put one out of human touch to a greater or lesser degree from those one has been close to. Those bonds need to be re-established for full recovery.      A spiritual recovery will also need to take place. One needs to un-brainwash oneself from the idea that one is one’s brain and is subservient to it. One might be intimately connected to one’s mind – which itself is non-physical and separate from the brain – but the mind  s much closer to one’s native spiritual identity than the brain. That truth that will need to be discovered or re-discovered and newly experienced for recovery. The manipulative “religion” of psychiatry is, in fact, the least spiritual religion on the planet.      Psychiatry a cult? Who knew?      There are eighty million Americans on anti-depressants who apparently don’t know, just as Kelsey Decker didn’t know she was part of The Bright Path cult. Better buy anybody you know taking antidepressants a copy of her Unofficial Survival Guide so they have a chance of extricating themselves from this dangerous psychiatric cult.

How Mistaking Relapse for Withdrawal Can Lead to ECT   May 15, 2026 – Robert Carter      Dr. Anders Sørensen, a Danish clinical psychologist specializing in psychiatric drug withdrawal, helps people taper safely off psychiatric drugs by using gradual, hyperbolic dose reductions. He also helps them work through any prior underlying emotional or mental symptoms. He is the author of Crossing Zero: The Art and Science of Coming Off and Staying Off Psychiatric Drugs .      He was recently invited to Washington DC to speak at the Mental Health and Over – medicalization Summit about how withdrawal from psychiatric drugs is repeatedly mistaken for relapse. That misidentification puts someone right back on their medication and, in some cases, even increases it. A complete transcript of his talk is on his May 8th Substack post.      Sorensen presented the key factors leading to this dangerous mis-identification and the ensuing and further over-medication of patients. He cites the 2025 study in The American Journal of Medicine which revealed that the major antidepressant trials available only follow medicated patients for eight weeks, on average.      That short duration of study shows little to nothing about the long term effects of those antidepressants on the body and the brain.      Consequently, the results of those short term trials are virtually worthless because the median duration of antidepressant use in America is a full five years. An eight week study has little practical applicability to those taking antidepressants in the real world.      Over that long term ingestion of antidepressants, Sorensen points out, the body adapts to its altered brain chemistry. The longer the duration of taking antidepressants, the harder it is for the body to adapt back again to a medication-free state. If someone tries to stop their medication too quickly, the system rebels and is thrown quite out of balance.      Hence, severe withdrawal symptoms. One begins to experience dizziness, nausea, headaches, muscle discomfort, shaking, burning sensations, and fatigue…in varying levels of intensity. Such abrupt drug cessation can be painful. One also experiences a host of debilitating emotional and mental states such as anxiety, panic, insomnia, irritability, depressed moods or mood swings, brain fog, difficulty concentrating and bothersome, unexpected thoughts.      In other words, these intense physical and emotional withdrawal symptoms can look like the patient is relapsing into the original symptoms of the initial diagnosis that started their antidepressant prescription in the first place.      When this misidentification occurs, the patient is then put back on the original medication, its dosage is often raised, other psychotropic drugs can be added to it, and when none of that full cocktail works, the patient is labeled “treatment resistant” and is given electroshock therapy, voluntarily or involuntarily.      Sorensen does not cover that in the transcript of his report to the Washington Summit, but that is what happens too often in the real world when proper, careful, slow tapering is not done and when psychiatrists are too blind to distinguish withdrawal from relapse.      And that gap matters. Especially when it comes to dependence and withdrawal.       Time matters. Because the body adapts.      If you alter brain chemistry for long enough, the body adapts – not overnight, but gradually, over months and years. And the longer that adaptation has been building, the more sensitive it becomes to change, and the harder it gets to come off.      In many cases, that means tapering over years. Because when you then remove the drug or reduce the dose too quickly –the system is thrown out of balance. That imbalance is what we call withdrawal; an imbalance between what the system expects – and what it gets.      What’s confusing is that withdrawal from psychiatric drugs isn’t just physical symptoms. It’s not just dizziness, nausea, headaches, muscle pain, shaking, burning sensations, fatigue. It’s that, too.      But it’s also anxiety, panic, insomnia, irritability, depressed mood, mood swings, brain fog, difficulty concentrating, intrusive thoughts. Withdrawal can mimic relapse. Or new diagnoses.

On-line AI Mental Health Chatbots: Feeding the Tapeworm May 1, 2026 – Robert Carter Richard Sears reported on the Mad in America website this week about a new AI mental health chatbot study just published in the Journal of Medical Internet  Research. A Syracuse University research team recruited 1805 participants between 18 and 49 years of age for their anonymous on-line survey about on-line AI mental health chatbot use. The invitation to participate was made through an on-line participant recruitment system that described the survey as focusing on perceptions and attitudes toward seeking mental health help, but it did not refer to AI. The overall question for this young to middle age audience was to name the sources they typically turn to when facing mental health concerns. Amazingly, a full one third of the respondents said they consulted an on-line AI chatbot at least once a week about mental health concerns. Participants who self-reported moderate to severe symptoms of depression or anxiety were 71 percent more likely to discuss their mental health with an AI chatbot. This was not the most scientifically exacting survey, of course, but was more a self-reported data collection. However, given such a significant number of participants, it does suggest an underlying tapeworm-like motif to AI mental health chatbot use. Just as an insatiably hungry tapeworm is caused by ingesting contaminated food, these heavy users of AI mental health chatbots develop an uncontrolled appetite for obsessive self-diagnosis aided by these AI programs. The original contamination? Their acceptance of a DSM-based label of a mental disorder for themselves. The enforced stigma of being so labeled – either by another or by themselves – sets off their insatiable search to solve this mystery about their mental make-up through hours of on-line interaction with these chatbots…programmed, of course, by the same minds that came up with the DSM labels in the first place. The sad irony is that there is no mystery solve about their mental health. There is only the original mental contamination from that false DSM label that they’ve been given. The sad, hopeless on-line pursuit that they’ve taken on to try to solve that unsolvable mystery is what follows. They’ve innocently ingested a DSM tapeworm that keeps trying to eat its own tail.

Big Pharma’s Gold Rush Mentality April 24, 2026 – Robert Carter The state of Utah is currently looking at a pilot program proposal that would authorize prescription refills for select psychiatric medications by an on-line AI software system, per an article published on Medscape this week. There is no concrete information yet on how the final program would work, but there is already concern about its legality and about patients being able to refill psychiatric medication without adequate safeguards. This new AI chatbot prescription program would be a product of the telehealth company Legion Health. Since late last year the state of Utah has already been using another AI prescription filling program designed by Doctronic, and a recent independent security review of their software by Mindgard, a cyber security research firm, has exposed some troubling flaws in the Doctronic AI program. Mindgard’s stress testing of a Doctronic AI chatbot software revealed some frailties in the healthcare system that make it a less than reliable program. When Mindgard gave the chatbot system adversarial prompts, they found the Doctronic AI recommended methamphetamine for “social withdrawal” and it mistakenly tripled one patient’s oxycodone dosage. Besides the risk of mis-programmed chatbot instructions, an AI based prescription refill program could also be illegal because neither Legion Health nor Doctronics are licensed practitioners, per the FDA’s standards for online prescriptions. While Utah’s desire to service its residents more efficiently through on line AI charbot software may be admirable, the apparently shaky technical and legal ground that Legion Health and Doctronic are operating on shows the gold rush mentality some firms are still exhibiting to take advantage of the huge profits available in the big pharma field. Doctronic recently posted recruitment ads as part of its expansion, and the copy for their Business Writer ad is telling. “Strategic thinker who understands what matters to enterprise buyers and can position accordingly, translate clinical validation data and regulatory milestones into compelling narratives that build trust and credibility, and write case studies, white papers, RFP responses, and partnership proposals that win enterprise deals.” The product of focus in the marketing copy they will produce is obviously sales, not sooth. On-line AI telehealth chatbot technology is the newest Big Pharma “gold fever,” and even forty years after the release of the original pharmaceutical blockbuster, Prozac — earned Eli Lilly over $22 billion in its first twelve year patent – today’s tech panhandlers are still looking for a quick get rich turnarounds through their forays into what is now “legal drug fever.”

Big Pharma’s Blockbuster Wages of Sin April 17, 2026 – Robert Carter A research letter published recently in The Journal of American Medicine reveals the enormous fines Big Pharma has paid from court cases indicting them for their many illegal kickback payments to psychiatrists, physicians, and patent advocates. The Yale study found that from 1999 to 2025 Big Pharma illegally paid out over $12.5 million dollars to inflence sales of their psychotropic drugs. Of course, they paid out a lot more “legally” to effect a similar influence. In 2024 alone they paid out $13 billion to physicians. From 2015 to 2022 they paid $100 million to psychiatrists in research money alone. That figure does not include speaking fees, consulting fees, travel, and other payments made to psychiatrists who altogether were paid $340 million by Big Pharma in just the six years from 2014 to 2020. Of course, all of those figures are a drop in the bucket compared to the annual revenue Big Pharma rakes in for its drug sales…an average of $2 billion per drug of the 105 drugs studied in the Yale article. Forty-nine of those drugs brought in more than $1 billion each in one year. Those most lucrative puppies are called “blockbusters” by Big Pharma. And how much does Big Pharma make altogether? More than $1.4 trillion in 2022. That’s the annual GDP of oil rich Saudia Arabia or of the international banking capital Switzerland. Big Pharma’s annual revenue is almost one hundred times that of all Mexican drug cartels combined from the sale of fentanyl, meth-amphetamine, cocaine, and their other equally lethal drugs. However, Big Pharma’s profit margin is much less than that of the Sinaloa and their cohort cartels. The sale of legal psychotropic drugs only made about 14 percent profit from 2000 to 2018. Still, that is twice what the average, legitimate Fortune 500 Company’s profit margin is. The wages of sin might be death, but until then Big Pharma is making a pretty good living hooking 80,000,000 American on antidepressants.

Big Pharma’s Three Card Monte April 10, 2026 – Robert Carter Shell companies, third party vendors, complex corporate structures. These are some of the financial ploys Big Pharma has used over the last twenty-five years to hide their outright bribery of government officials, inspectors, regulators and private physicians. Big Pharma has worked hard to hide their illegal payments to ensure approval for drugs that did not meet safety standards and to evade regulatory restrictions for unapproved off-label sales of their drugs to increase their own already huge profit margins. A new study from the University of Toronto just published in the Journal of Law, Medicine and Ethics exposes long term planning, executing, and approving of these bribery strategies by everyone from the sales and distribution personnel through the middle managers and local executives right up to high-ranking corporate officers of most all pharmaceutical companies, including Pfizer, J and J, Eli Lilly, BMS, AstraZeneca, and GSK. The study searched through financial reports from 1999 to 2025 made to the Organization for Economic Co-operation and Development Working Group on Bribery and found illicit paymentswere made by Big Pharma which totaled $12,633,989.00. Those pharmaceutical companies that were prosecuted and convicted then had to pay over $1,000,000,000 in sanctions, fines, returned profits, and prejudgment interest. Big Pharma has been rife with financial corruption for the last twenty-five years. These fines are for illegal, three card monte type business practices and are separate from the many billions Big Pharma has also paid out for lawsuits over the damage caused to individuals by their psychotropic drugs. The study also concedes that this level of bribery and corruption may only be the tip of the iceberg for Big Pharma. Smaller firms in the pharmaceutical industry that have escaped detection, companies in areas with more lax oversight or enforcement, and companies that have made bribery settlements confidentially will not have appeared in these OECD records. The authors conclude that “these findings underscore the systemic nature of bribery in the pharmaceutical sector.” Enough said. And these are the guys the American public is trusting to medicate us safely and effectively – per their multi-billion dollar marketing campaigns — for every little emotional wrinkle life presents? Caveat emptor. Thanks to Richard Sears for bringing this study to light in his news article on this week’s Mad in America website.

Big Pharma’s Font for Lies Is Always Boldface March 26, 2026 – Robert Carter Dr. Josef Witt-Doerring made this request at the end of his Monday Facebook post this week: “If you believe people deserve informed consent before being handed a psychiatric medication in a seven-minute appointment, share this post.” We’re honoring his request here. In a response to the U.S. Secretary of Health and Human Services RFK’s now looking into the over-prescription of America, leaders from America’s psychiatric community recently issued a public statement in defense of the safety and the effectiveness of psychiatric medications. The lies they include there are so boldface, it is stunning. Dr. Josef read through the entire text of their argument and said, “It is one of the most masterful efforts at deception I have seen in a long time” and equivalent to those medical experts who, contrary to all the available evidence, used to deny that smoking causes cancer. The organizations that issued the pro-drug, Big Pharma statement are either heavily funded by the pharmaceutical industry or run by individuals with their own deep financial ties to the pharmaceutical industry. Their statement claims that psychiatric medications are both safe and effective, and in it they attack anyone raising any concerns about that and they imply they are putting lives at risk by trying to deny the “mentally ill” public those drugs. If the drugs were effective, that might be true. But they are not. First, the clinical trials that show that these medications are safe and effective usually only run for three months or less, but half of all Americans who take antidepressants have been taking them for more than five years. There is no rigorous long-term evidence from any study which shows what these drugs actually do to a person, mentally or physically, over the long term. Second, the “relapse prevention” studies that have been made about psychotropic drugs only medicate their subjects for six months and then abruptly switch half the control group to a placebo, sometimes with as little as five days of tapering off the drug. Of course they show a relapse of their condition, but it is not a relapse. It is simply harsh withdrawal symptoms from ceasing the heavy duty medication so abruptly. Those last two paragraphs, you’ll notice, are not in boldface. They don’t have to be. They contain no lies. Thank you, Dr. Josef, for all the good work you do. We’re more than happy to share your message. Who Knows? Maybe even RFK Jr. will read it.

Big Pharma Bribes to Psychiatrists: How Much Difference If They’re Disclosed? March 22, 2026 – Robert Carter The medical journal BMJOpen recently published a study that revealed that $645,135 of Big Pharma payments to authors publishing in the American Journal of Psychiatry and the Journal of the American Medical Association Psychiatry were undisclosed between 2020 and 2022. Most of these were research payments to these authors and the study voices concern about the conflict of interest suggested by this amount of “silent” money and its influence on the credibility of the research. That’s a valid concern, of course. Why would these doctors, mostly psychiatrists, not want to disclose these payments if the subsequent research was valid? Withholding reporting a substantial payment like that becomes suspicious because only 14 percent of all such payments to these authors were undisclosed. The ten authors receiving the highest amount of undisclosed payments had worked in 12 randomized control trials, 11 of which were for new psychotropic drugs. Big Pharma rakes in tens of billions of dollars every year from psychotropic drugs. However, that $645,135 is a drop in the bucket compared to the fully disclosed $4,539,207 paid to these authors by Big Pharma during the three year period of the study. $895,000 of that four and a half million was in “general” payments and $3,644,100 was in research payments. The American Journal of Psychiatry authors received about twice as much money as the Journal of the American Medical Association Psychiatry authors did. The fact that some of these authors disclosed their four and a half million dollars in payments is legally praiseworthy, of course, but does that lessen the conflict of interest possible from that much Big Pharma money, disclosed or undisclosed? Bribery is persuading another to act in one’s favor — illegally or dishonestly – because of a gift of money or other inducement. Not only have these authors received enormous amounts of money, they have also fattened up their resumes by putting their names on Big Pharma trials for new psychotropic drugs and then publishing their results in these two psychiatric journals. And their “improved” research reputation can then make them even more eligible for further bribes, no?